جست‌وجوی استاد و پژوهشگر

• Cardiovascular Medicine
• Atrial Fibrillation
• Digital Health
• +۷ مورد دیگر

David D. McManus, MD , is the Chair and Professor of Medicine at UMass Chan Medical School , where he also holds the Richard M. Haidack Professor in Medicine endowed title. He is affiliated with multiple departments across T.H. Chan School of Medicine and Morningside Graduate School of Biomedical Sciences , including Cardiovascular Medicine, Population and Quantitative Health Sciences, and Clinical Investigation. Education: Brown University – BS in Biological Sciences University of Massachusetts Medical School – MD University of Massachusetts Medical School – MS in Clinical Investigation Research Interests: McManus is a leading figure in cardiovascular medicine and digital health innovation . His research spans atrial fibrillation screening and management , wearable device validation , home-based cardiac monitoring , stroke prevention , hypertension , and population health informatics . He leads large-scale trials such as the GUARD-AF and VITAL-AF studies, evaluating the utility of wearable ECG devices in detecting undiagnosed atrial fibrillation. His work also includes COVID-19 diagnostics , digital therapeutics , and AI applications in cardiology . Scientific Awards & Recognition: While specific awards are not listed, McManus's prolific publication record and leadership roles in national and international trials underscore his prominence in cardiovascular and digital health research. Grants & Funding: He has received funding from NIH and other major bodies for trials such as GUARD-AF, VITAL-AF, and digital health interventions for stroke survivors and COPD patients. Labs & Teams: McManus leads interdisciplinary teams across UMass Medical School, collaborating with experts in cardiology, data science, behavioral science, and health informatics. His work integrates clinical research with real-world digital health implementation.

Mohammed Aliمشاهده پروفایل

استاد

• Diabetes
• Global Health
• Cardiovascular Diseases
• +۳ مورد دیگر

Mohammed K. Ali is a Professor at Emory University, affiliated with the Department of Epidemiology and the Hubert Department of Global Health . A global health expert with a transnational academic journey, he holds a medical degree from the University of Cape Town , dual master's in cardiovascular medicine and global health from the University of Oxford , and an MBA from Emory University . Co-Director, Emory Global Diabetes Research Center Vice Chair (Research), Department of Family and Preventive Medicine Scientific Consultant, CDC Division of Diabetes Translation (since 2010) Advisor to WHO, World Bank, and National Academy of Medicine Research Interests focus on cardiometabolic health, diabetes prevention, implementation science, and health systems strengthening. His work bridges epidemiology with business insights to optimize preventive healthcare delivery. Scientific Awards include: Rhodes Scholar (2005) Fellow of the American Heart Association (2014) Multiple teaching and research awards As a Primary Care Physician at The Emory Clinic and member of global health organizations' leadership councils, he integrates clinical practice with academic innovation.

Edmund Beckerمشاهده پروفایل

استاد

• Health Policy
• Healthcare Systems
• Health Disparities
• +۳ مورد دیگر

Edmund Becker is a Professor in the Department of Health Policy and Management at Emory University. He previously served as Senior Research Associate at Harvard School of Public Health and led the Resource-Based Relative Value Scale (RBRVS) project, foundational to Medicare physician payment systems. His academic background includes roles at Vanderbilt University and the University of Colorado at Denver. He holds a PhD from Vanderbilt University, an MA from Ohio University, and a BS from Westminster College. Research interests focus on healthcare costs, outcomes, policy, and disparities. Notable projects include evaluating Medicaid provider prescription patterns, hospital performance benchmarking, and the impact of healthcare payment reforms. He serves on Emory Healthcare's Medical Practice Committee and the Accountability Review Council for Philadelphia's school reforms. His 100+ publications span cost analysis, payment systems, and surgical outcomes. Recent work addresses nurse staffing impacts on mortality and EHR effects on patient safety. Awards include Distinguished Alumni recognition from Ohio University (2005) and Westminster College (2009).

Jaap Keijerمشاهده پروفایل

استاد

• Energy metabolism
• Mitochondrial function
• Metabolic pathways
• +۷ مورد دیگر

Jaap Keijer is a Full Professor and Chairholder in the Department of Human and Animal Physiology at Wageningen University & Research. His research focuses on metabolic physiology, particularly energy metabolism, mitochondrial function, and the interplay between diet, aging, and chronic metabolic diseases. He leads projects investigating nicotinamide nucleotide transhydrogenase (NNT) in energy metabolism, galactose's effects on metabolic programming, and the role of environmental factors like hypoxia in muscle physiology. He serves on the editorial board of Molecular Nutrition and Food Research and advises the German Institute of Human Nutrition. His work integrates molecular, cellular, and whole-organism approaches to understand health and disease mechanisms. Key research themes include metabolic adaptations in obesity, mitochondrial dysfunction in aging, and translational biomarker development for physical activity and metabolic health. Dr. Keijer teaches courses on molecular nutritional physiology, model organisms for lifespan research, and dissection-free human/animal physiology. His projects address clinical challenges such as sarcopenia, atrial fibrillation, and nutrient interventions for metabolic disorders. Recent studies explore dietary galactose's programming effects on intestinal metabolism and the impact of NNT deficiency on cardiac health. His lab employs advanced techniques like single-cell transcriptomics and Seahorse extracellular flux analysis to study metabolic pathways in humans and animal models. Publications emphasize mitochondrial dysfunction, metabolic biomarkers, and translational models for aging and disease. His work bridges basic research and clinical applications, aiming to improve metabolic health through dietary and lifestyle interventions. Current initiatives include developing a human gut-on-a-chip model and validating integrative biomarkers for physical activity in adolescents.

• Biomedical engineering
• Tissue engineering
• Regenerative medicine
• +۸ مورد دیگر

Professor Travis Klein leads the Cartilage Regeneration Laboratory at Queensland University of Technology (QUT) within the School of Mechanical, Medical and Process Engineering. His research spans biomedical engineering, focusing on cartilage regeneration, biofabrication, and development of advanced biomaterials for regenerative medicine. PhD in Bioengineering from University of California Co-founder of Gelomics Pty Ltd Founding Director of QUT Centre for Biomedical Technologies Klein's work integrates biomaterials , stem cell research , and mechanobiology to develop regenerative therapies for cartilage defects and osteoarthritis. His group applies similar technologies to cardiovascular and cancer applications through 3D cell culture systems and bioreactor engineering. Recent publications focus on hydrogel modifications , electrowriting techniques , and dynamic bioreactor systems for tissue engineering. His research has been recognized through competitive ARC fellowships and principal research roles in major grant projects. Recipient of 2011 ARC Industrial Transformation Training Centre Fellowship 2008 Australian Postdoctoral Fellowship awardee As an educator, Klein coordinates EGH438 - Biomaterials and ENN532 - Safety and Environmental Management , while lecturing in engineering mechanics and advanced manufacturing. He also supervises final year engineering projects ( EGH400 ).

• Internal Medicine
• Clinical Quality Improvement
• Cardiovascular Disease Management
• +۳ مورد دیگر

Margaret Izabella Chustecki is an Associate Clinical Professor at the Yale School of Medicine's Department of Internal Medicine. She obtained her MD from Warsaw Medical School (1988) and an MBA from the Yale School of Management (2009). Her clinical practice focuses on improving healthcare efficiency through quality programs achieving NCQA accreditation and implementing initiatives like Meaningful Use and PQRS. She coordinates medical education for trainees while maintaining an active clinical practice. Education: MD - Warsaw Medical School (1988), MBA - Yale School of Management (2009) Clinical Experience: Extensive inpatient/outpatient internal medicine, hospitalist service leadership Practice Management: Founded Internal Medicine of Greater New Haven in 2003 Her research interests center on cardiovascular disease management, diabetes therapies, and healthcare quality improvement. She has led over 30 clinical trials evaluating treatments for cardiovascular conditions, diabetes, COPD, migraines, and osteoarthritis. Key areas of investigation include statin efficacy, anticoagulant therapies, and novel diabetes medications. Dr. Chustecki's clinical trials portfolio demonstrates expertise in cardiology, endocrinology, and gastroenterology. Recent studies focus on residual cardiovascular risk reduction, type 2 diabetes combination therapies, and migraine treatment innovations. Her work bridges clinical practice improvements with rigorous evidence-based research. Teaching contributions include supervising Yale medical students, PA trainees, and residents in both hospital and ambulatory settings. She actively participates in medical education program development and interprofessional team coordination. Labs/Teams: Collaborates with Yale New Haven Hospital teams in clinical trial execution and quality improvement initiatives.

• Cardiac Arrhythmias
• Cardiovascular Diseases
• Metabolic Signaling and Mitochondrial Biology
• +۵ مورد دیگر

Dr. Fadi Gabriel Akar is a Professor of Medicine (Cardiovascular Medicine) and Biomedical Engineering at Yale University School of Medicine. He holds affiliations with the Cardiovascular Medicine Department, the Yale Cardiovascular Research Center, and the Molecular Medicine Program. His primary appointment is as a Professor in the Department of Medicine, specializing in cardiovascular research and translational medicine. Dr. Akar’s research focuses on unraveling mechanisms promoting arrhythmias in structural heart diseases and developing gene-based therapies to prevent malignant arrhythmias. His lab investigates mitochondrial dysfunction, metabolic signaling, and mechano-electrical feedback in arrhythmogenesis, with a translational pipeline from target identification to pre-clinical testing in large animal models. Key areas include arrhythmias in heart failure, myocardial infarction, obesity, diabetes, atrial fibrillation, and pulmonary hypertension. Notable achievements include his role as Chairman of the AHA Cardiac Electrophysiology Fellowships Committee (2022). His work bridges basic science and clinical applications, emphasizing mechanism-based therapies over traditional antiarrhythmic approaches. Collaborations include studies on AMPK deletion models, mitochondrial network remodeling, and resolvin D1’s role in post-MI atrial remodeling. Publications highlight contributions to understanding arrhythmia mechanisms in metabolic diseases, mitochondrial dysfunction, and translational therapies. His research is supported by NIH grants and industry partnerships, focusing on advancing diagnostics and treatments for electrical cardiac disorders.

• Cardiology
• Pulmonary Medicine
• Cardiovascular Disease
• +۷ مورد دیگر

Jafar Alzubi is a Researcher in the Department of Internal Medicine at Yale School of Medicine. His work focuses on cardiovascular and pulmonary conditions with particular emphasis on cancer-cardiovascular comorbidities, interventional cardiology, and diagnostic imaging innovations. His research explores the intersection of malignant diseases with cardiovascular systems, device-based therapies, and critical care management. Key research areas include pulmonary embolism treatment strategies in oncology patients, left atrial appendage closure techniques, and the diagnostic utility of advanced echocardiography. He has investigated outcomes of spontaneous coronary artery dissection, non-bacterial thrombotic endocarditis, and Takotsubo cardiomyopathy in transplant recipients. His recent publications highlight trends in cardiovascular device performance, predictive modeling for disease progression (e.g., aortic stenosis), and epidemiological insights into sepsis mortality demographics. Notably, he has contributed to understanding how modern imaging modalities like 3D echocardiography improve diagnostic accuracy for conditions like infective endocarditis. No scientific awards have been listed. His advisory and grant activities remain unspecified in available records. He is affiliated with Yale University's clinical and research teams in cardiology and critical care medicine.

Jonathan Swannمشاهده پروفایل

استاد

• Biomolecular Medicine
• Metabolomics
• Gut Microbiota
• +۵ مورد دیگر

Dr. Jonathan Swann is a Professor of Biomolecular Medicine at the University of Southampton's Faculty of Medicine, School of Human Development and Health. He leads a metabolomics-focused research program investigating gene-environment interactions in health and disease. His work spans two main themes: (1) Gut microbiota's role in host health/disease, including gut-brain axis communication, microbiome-cancer interactions, and microbial metabolism; (2) Early-life environmental influences on development, particularly in global health contexts. He supervises multiple PhD students and collaborates with institutions like Imperial College London and Karolinska Institute. Research affiliations: Institute for Life Sciences, Nutrition, Endocrinology and Metabolism, and 8 other interdisciplinary groups Funding: BBSRC, MRC, Wellcome Trust, NIH, Gates Foundation Recent studies explore microbiota's impact on neurological disorders, malnutrition consequences in children, and metabolic biomarkers in pancreatic cancer. His 2024 Nature Communications paper revealed circadian bile acid rhythms in humans, while 2025 cancer biomarker work advances early detection methods. External roles include editorial board positions for Microbiome and Frontiers in Endocrinology , plus expert advisory roles with the British Society of Gastroenterology.

Sonit Singhمشاهده پروفایل

مدرس

• Artificial Intelligence
• Computer Vision
• Natural Language Processing
• +۷ مورد دیگر

Dr. Sonit Singh is a Lecturer at the School of Computer Science and Engineering at the University of New South Wales (UNSW), Sydney, Australia. Prior to this role, he served as a Postdoctoral Research Fellow at the same institution. He holds a PhD from Macquarie University, completed in collaboration with Macquarie. His research focuses on artificial intelligence, computer vision, natural language processing, and their applications in healthcare, particularly in medical imaging and diagnostic systems. Dr. Singh's academic background includes a strong emphasis on biomedical imaging, intelligent robotics, and computing education. His work bridges machine learning advancements with real-world clinical challenges, such as tumor segmentation, radiology report generation, and disease detection through imaging modalities like CT scans and ultrasound. His recent publications highlight innovations in 3D medical image localization, robust tumor segmentation networks, and clinical context-aware radiology report systems. These contributions underscore his expertise in integrating deep learning techniques with healthcare workflows. Dr. Singh collaborates with multidisciplinary teams, including medical professionals, to develop solutions for challenges like placenta segmentation and dietary intake monitoring using AI. While no specific awards or grants are explicitly listed, his extensive publication record reflects sustained academic engagement in high-impact areas. His research often addresses practical clinical needs, such as improving diagnostic accuracy and patient care through advanced computational methods.

• Causal Inference
• Clinical Trials
• Statistical Methods
• +۷ مورد دیگر

Dr. Alisa Stephens Shields serves as an Associate Professor in the Biostatistics Division of the Department of Biostatistics, Epidemiology and Informatics at the University of Pennsylvania Perelman School of Medicine. She also holds an adjunct faculty position at Harvard University where she earned her PhD in Biostatistics. Her leadership extends to directing the Biostatistics and Data Science Core at the Penn Center for AIDS Research (CFAR) and chairing the Student Recruitment Committee for Penn Biostatistics. Her educational background includes: BS in Mathematics from University of Maryland (2006) AM in Biostatistics from Harvard University (2009) PhD in Biostatistics from Harvard University (2012) Dr. Stephens Shields' research focuses on enhancing clinical trial design and analysis through innovative applications of causal inference methods. She has made significant contributions to patient-reported outcome development for population-appropriate trial endpoints, particularly in areas of pediatrics, chronic pain, urology, and infectious disease. Her work bridges statistical methodology with real-world health challenges, addressing issues of diversity in clinical trials and improving trial generalizability for complex, heterogeneous conditions. Analysis of Dr. Stephens Shields' publication record reveals a consistent trajectory of methodological innovation applied to pressing clinical problems. Her work spans from foundational statistical methods (particularly in causal inference) to direct applications in clinical research domains such as chronic pelvic pain, infectious disease, and cardiovascular health. A notable trend is her increasing focus on behavioral economic approaches to address diversity gaps in clinical trial participation, reflecting her commitment to health equity. Her scientific recognitions include: 2024 Myrto Lefkopoulou Distinguished Lectureship 2021 Committee of Presidents of Statistical Societies Leadership Award 2018 Distinguished Faculty Award, University of Pennsylvania Fellow of the American Statistical Association Dr. Stephens Shields demonstrates exceptional leadership in mentoring and educational initiatives. She co-developed a causal inference course for Penn's Master of Science in Clinical Epidemiology program and directs the Design of Interventional Studies course for doctoral students. As chair of the Student Recruitment Committee, she actively fosters diversity in quantitative health careers and regularly participates in diversity-focused workshops including the ENAR Fostering Diversity Workshop and STATFest. Her mentorship extends beyond Penn through her adjunct role at Harvard University. Dr. Stephens Shields leads or contributes to several significant research teams and initiatives including the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network, the Randomized Evaluation of Trial Acceptability by Incentive (RETAIN) trial, the Behavioral Economics to Transform Trial Enrollment Representativeness (BETTER) Center, and the Handoffs and Transitions in Critical Care research program. Her role as director of the Biostatistics and Data Science Core at CFAR demonstrates her leadership in HIV research methodology and statistical mentorship.

Lacy Alexanderمشاهده پروفایل

استاد

• Microvascular Function
• Human Cutaneous Circulation
• Cardiovascular Disease
• +۴ مورد دیگر

Lacy Alexander is a Professor of Kinesiology and Research Professor in Charge at The Pennsylvania State University’s Department of Kinesiology, within the College of Health and Human Development. Her research focuses on microvascular dysfunction mechanisms in diseases like hypertension and aging, using the cutaneous circulation as a model. She holds a Ph.D. (2007) and M.S. (2002) in Kinesiology/Human Physiology from Penn State and University of Oregon. Her work investigates nitric oxide signaling, inflammatory pathways, and pharmacological interventions (e.g., aspirin) in vascular health. Key research areas include thermal regulation, endometriosis-related cardiovascular risks, and preeclampsia aftermaths. She leads NIH-funded projects and has published over 129 peer-reviewed articles. Notable studies address heat stress mitigation in vulnerable populations, estrogen’s role in endothelial function, and holistic endometriosis care. Affiliations include the Center for Healthy Aging and Integrative and Biomedical Physiology. She co-edits the Journal of Applied Physiology and actively promotes gender equity in science. Her grants total over $5 million, emphasizing translational research in vascular biology and clinical applications.

• Health Behavior Psychology
• Sport and Exercise Psychology
• Self-Regulation Processes
• +۳ مورد دیگر

Martin Hagger is a Professor at the University of Jyväskylä's Faculty of Sport and Health Sciences, specializing in sport and exercise psychology. His research focuses on psychological determinants of health behaviors, self-regulation processes, and theoretical integration of motivation frameworks (e.g., Self-Determination Theory). He leads the 'YEAH! Youth hEAlth from a Holistic perspective' project (EU-funded) and co-leads studies on physical activity interventions for families and schools. Core affiliations: Sport and Exercise Psychology research group (LPS), Department of Sport Sciences Recent grants: € funding from the European Commission and Finnish Ministry of Education Research interests include behavioral change mechanisms, intervention design, and meta-analytic evaluation of health behavior theories. Notable contributions include a 2025 Annual Review of Psychology paper synthesizing psychological health behavior determinants and their application in intervention development. Publications emphasize contextual factors (e.g., environmental aesthetics, parental behavior) and cognitive processes (e.g., inhibitory control, implicit attitudes) shaping health-related actions. His work bridges theoretical psychology with applied public health challenges.

Wilma Nusselderمشاهده پروفایل

استادیار

• Medical Demography
• Public Health
• Health Inequalities
• +۱۳ مورد دیگر

Wilma Nusselder, PhD, is an Assistant Professor in Medical Demography at the Department of Public Health, Erasmus University Medical Center (Erasmus MC), Rotterdam, the Netherlands. She is actively engaged in research at the intersection of public health and demography, with a strong focus on health and mortality inequalities by socioeconomic position, gender, and ethnicity. Her research centers on the development and application of summary measures of population health, particularly health expectancies, to understand both the quantity and quality of life across populations. She investigates how risk factors and chronic diseases influence health trajectories and mortality, and evaluates the impact of public health interventions and policies. Her methodological expertise includes life table analysis, decomposition methods, and modeling frameworks such as DYNAMO-HIA and ERAINHE. The analysis of her recent publications reveals a consistent focus on health disparities, particularly educational and socioeconomic inequalities in life expectancy, disability, and chronic disease. Her work increasingly employs comparative international data, simulation modeling, and policy impact assessment, reflecting a trend toward evidence-based public health strategy and forecasting. Dr. Nusselder is the coordinator of ERAINHE, a collaborative European framework for harmonizing mortality data by socioeconomic position, enabling large-scale comparative research. She teaches medical and PhD students and collaborates extensively with multidisciplinary teams across public health, demography, sociology, and econometrics. She has contributed to numerous research projects and publications assessing the societal and health system impacts of policies, particularly in aging and health equity. Her work aligns with UN Sustainable Development Goal 3 (Good Health and Well-being), especially in reducing health disparities.

Ulrich H.E. Hansmannمشاهده پروفایل

استاد

• Biophysical Chemistry
• Protein Folding
• Aggregation Mechanisms
• +۳ مورد دیگر

Ulrich H.E. Hansmann is a Professor in the Department of Chemistry and Biochemistry at the University of Oklahoma. He holds a Ph.D. from Freie Universität Berlin (1990), followed by postdoctoral research at Florida State University and ETH Zürich. His research focuses on computational biophysical chemistry, specifically protein folding, aggregation, and enhanced sampling techniques. His lab develops algorithms and software, such as the SMMP package, to study biomolecular processes relevant to diseases like Alzheimer’s and cancer. Recent work includes investigating the role of microbial infections in amyloidogenesis and SARS-CoV-2 interactions with proteins. He leads the Hansmann Group, which collaborates on projects involving protein-ligand binding and membrane interactions. Education: M.A. (1983), Diplom (1985), Ph.D. (1990) from Freie Universität Berlin. Research Keywords: Protein folding, aggregation, enhanced sampling, amyloidosis, computational modeling. His research explores mechanisms of protein misfolding and aggregation, with applications in drug design and disease pathology. Collaborations include studies on viral proteins’ effects on amyloid formation and antibiotic peptide stability. The SMMP software, developed by his group, enables efficient simulations of large biomolecules.